BOSTON THERAPEUTICS, INC. 10% CONVERTIBLE PROMISSORY NOTE DUE SEPTEMBER 24, 2018Boston Therapeutics, Inc. • October 2nd, 2015 • Pharmaceutical preparations • New Hampshire
FOR VALUE RECEIVED, BOSTON THERAPEUTICS, INC., a Delaware corporation (the “Company”), hereby promises to pay to the order of CJY HOLDINGS LIMITED (“Holder”), the principal amount of SEVEN HUNDRED FIFTY THOUSAND DOLLARS ($750,000) on September 24, 2018 (“Maturity Date”) or earlier as hereinafter provided. Interest on the outstanding principal balance shall be paid at maturity at the rate of twelve percent (10%) per annum. Interest shall be computed on the basis of a 360-day year, using the number of days actually elapsed.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 2nd, 2015 • Boston Therapeutics, Inc. • Pharmaceutical preparations • New Hampshire
SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of September 24, 2015, by and among Boston Therapeutics, Inc., a Delaware corporation, with headquarters located at 1750 Elm Street, Suite 103, Manchester, NH 03104 (the “Company”), and the purchaser set forth on the signature page hereto (the “Buyer”).
